Pamela L.Taylor (Pam)

Of Counsel

Chicago + 1.312.269.4327

Pam Taylor is an antitrust lawyer with more than 20 years of experience in antitrust and competition law issues, including the antitrust aspects of mergers, joint ventures, and government investigations. She represents clients in government antitrust investigations and enforcement actions before the Federal Trade Commission and the Department of Justice Antitrust Division. She also advises companies on Hart-Scott-Rodino premerger notification requirements, strategic alliances, pricing and price discrimination, marketing practices, distribution issues, dealer terminations, and Hatch-Waxman Act strategies.

Pam has provided antitrust advice to global companies on their distribution strategies for the United States.

Pam's recent representations include serving as antitrust counsel to Baxter International in its acquisition of Claris Injectables and to Baxalta in its $32 billion merger with Shire. Other representative clients include Abbott Laboratories, Boehringer Ingelheim, Cardinal Health, Hill-Rom, Infant Formula Council of the Americas, Veolia Environnement, and Zekelman Industries. Pam also has served as antitrust counsel to trade associations and counseled trade associations and members on standard-setting activities.

Pam is a member of the Illinois bar and serves on the board of the Legal Aid Society.

Experience

  • Riverside and Investcorp sell Arrowhead Engineered Products to GenstarJones Day advised The Riverside Company in the sale of Arrowhead Engineered Products to Genstar.
  • Riverside acquires Corporate VisionsJones Day represented The Riverside Company in connection with the acquisition and financing of Corporate Visions, a leading provider of science-backed sales, marketing, and customer success training solutions to global Fortune 1000 companies.
  • Follett sells Follett School Solutions to Francisco PartnersJones Day advised Follett Corporation in the sale of Follett School Solutions to Francisco Partners.
  • Riverside sells portfolio company Greenphire to Thoma BravoJones Day represented The Riverside Company in connection with the sale of portfolio company Greenphire, the global leader in financial lifecycle management software for clinical trials, to Thoma Bravo, a software focused private equity firm.
  • Eastman sells tire additives business product lines to One Rock Capital PartnersJones Day advised Eastman Chemical in the $800 million sale of the rubber additives (including Crystex™ insoluble sulfur and Santoflex™ antidegradants) and other product lines and related assets and technology of the global tire additives business of its Additives & Functional Products segment to an affiliate of One Rock Capital Partners, LLC.
  • Morgan Stanley Capital Partners acquires Nivel Parts & ManufacturingJones Day advised Morgan Stanley Capital Partners in the acquisition and financing of Nivel Parts & Manufacturing Co., LLC, a global manufacturer, distributor, and seller of aftermarket parts and accessories for niche vehicles and heavy-duty equipment.
  • HCI Equity Partners sells Go To LogisticsJones Day represented HCI Equity Partners in connection with the sale of Go To Logistics, a transportation and logistics service provider focused on the freight consolidation and LTL (less-than-truckload) market, to Stellex Capital Management.
  • Riverside to sell ARCOSJones Day is advising The Riverside Company in its sale of ARCOS, the market leader in resource management software for utilities, airlines, and other critical infrastructure industries, to Vista Equity Partners.
  • High Road Capital sells portfolio company General Tools & Instruments Company LLC to Worthington Industries, Inc.Jones Day represented High Road Capital Partners in connection with the sale of portfolio company General Tools & Instruments Company LLC, a provider of over 1,200 feature-rich, specialized tools with well-established brands, to Worthington Industries, Inc.
  • Transtar Holding Company sold to Blue Point Capital PartnersJones Day advised Transtar Holding Company, a portfolio of industry-leading automotive aftermarket and original equipment businesses with a focus on high-quality products and unmatched customer service, in the sale of majority ownership to Blue Point Capital Partners.
  • Riverside portfolio company acquires TriLink Saw Chain, LLCJones Day represented The Riverside Company in connection with the acquisition and financing by portfolio company Arrowhead Engineered Products, Inc. of substantially all of the assets of TriLink Saw Chain, LLC, a leading distributor of chainsaw chains, guide bars, and other accessories used in the arborist and forestry industries.
  • HD Supply acquired by The Home Depot, Inc. for $8.8 billionJones Day advised HD Supply, Inc. ("HDS") in its $8.8 billion acquisition by The Home Depot, Inc. ("Home Depot").
  • MPE Partners sells its DreamLine platform to American Bath Group, LLCJones Day advised MPE Partners on the sale of its DreamLine platform to American Bath Group, LLC.
  • Riverside Company invests in Clinical Education AllianceJones Day advised The Riverside Company in connection with its investment in and financing of Clinical Education Alliance, LLC (CEA), a provider of interactive live and web-based certified continuing medical education (CME) activities and related training for healthcare professionals.
  • DataBank acquires zColo for $1.4 billionJones Day advised DataBank, a leading provider of enterprise-class colocation, connectivity, and managed services, in connection with the acquisition and financing of zColo, including certain U.S. and European data center assets, from Zayo Group Holdings, Inc. for $1.4 billion.
  • USI Insurance Services acquires Findley, Inc.Jones Day advised USI Insurance Services, a top 10 insurance broker, in connection with its acquisition of the stock of Findley, Inc., a leading independent human resources and employee benefits consulting firm, providing actuarial, benefits and administrative consulting services to private and publicly held companies, the public sector, and non-profit organizations.
  • Astellas Pharma acquires iota BiosciencesJones Day advised Astellas Pharma Inc. in its acquisition of iota Biosciences.
  • Riverside portfolio company acquires INVIVO CommunicationsJones Day represented The Riverside Company in connection with the acquisition and financing by portfolio company Red Nucleus of INVIVO Communications, a Toronto-based digital scientific communications provider strategically focused on the medical affairs space.
  • CDPQ participates in $185 million Series G financing round of AppDirect, Inc.Jones Day represented Caisse de dépôt et placement du Québec in connection with its participation in the $185 million Series G financing with existing investors into AppDirect, Inc., which offers a subscription commerce platform for digital services.
  • Vantage Data Centers forms $3.5 billion strategic partnership with Colony Capital to advance data center growthJones Day advised Vantage Data Centers, a leading global provider of hyperscale data center campuses, on forming a strategic partnership with Colony Capital, Inc. valued at $3.5 billion to accelerate the expansion of Vantage’s best-in-class, wholesale data centers throughout North America and Europe.